A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia | NEJM
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by autoantibody-mediated platelet destruction. Treatment with CM313, a novel anti-CD38 monoclonal antibody, can result in target…